Hsa_circ_0032131 knockdown inhibits osteoarthritis progression via the miR-502-5p/PRDX3 axis

被引:13
|
作者
Xu, Jin [1 ]
Ma, Xinlong [1 ]
机构
[1] Tianjin Hosp, Dept Pain Treatment, Tianjin 300211, Peoples R China
来源
AGING-US | 2021年 / 13卷 / 11期
关键词
circRNA; OA; NF-KAPPA-B; MATRIX DEGRADATION; II COLLAGEN; CHONDROCYTES; APOPTOSIS; CARTILAGE; INFLAMMATION; EXPRESSION; AGGRECAN; SPONGE;
D O I
10.18632/aging.203073
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Osteoarthritis (OA) is a chronic disease characterized by progressive loss of cartilage and failure of the diarthrodial joint. Circular RNAs (circRNAs) are known to participate in the pathogenesis of multiple diseases, including OA. We investigated the functions of hsa_circ_0032131, a circRNA upregulated in OA, using CHON-001 cells and an in vivo OA rat model. CHON-001 cells were treated with interleukin (IL) -113 to mimic OA in vitro. IL 113 -induced inhibition of CHON-001 growth was reversed by silencing hsa_circ_0032131. In addition, hsa_circ_0032131 knockdown reversed IL-113 -induced activation of Trx1, Cyclin D and PRDX3, whereas overexpression of PRDX3, a direct target of miR-502-5p, reversed this effect. Hsa_circ_0032131 served as a competing endogenous RNA for miR-502-5p. Moreover, knockdown of hsa_circ_0032131 attenuated OA symptoms in vivo by inactivating the STAT3 signaling pathway. Thus, silencing of hsa_circ_0032131 inhibited the progression of OA by inactivating the miR-502-5p/PRDX3/Trx1/STAT3 axis, which highlights its potential as a therapeutic target for OA.
引用
收藏
页码:15100 / 15113
页数:14
相关论文
共 50 条
  • [1] Knockdown of circSOD2 ameliorates osteoarthritis progression via the miR-224-5p/PRDX3 axis
    Hao Li
    Yong Cao
    Chongfei Chang
    Wenping Huang
    Songchuan Su
    Zhenggang Peng
    Jiajin Zhang
    Journal of Orthopaedic Surgery and Research, 18
  • [2] Knockdown of circSOD2 ameliorates osteoarthritis progression via the miR-224-5p/PRDX3 axis
    Li, Hao
    Cao, Yong
    Chang, Chongfei
    Huang, Wenping
    Su, Songchuan
    Peng, Zhenggang
    Zhang, Jiajin
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2023, 18 (01)
  • [3] Hsa_circ_0000231 knockdown inhibits the glycolysis and progression of colorectal cancer cells by regulating miR-502-5p/MYO6 axis
    Yanhe Liu
    Hui Li
    Xiaoyi Ye
    Anlong Ji
    Xiangwei Fu
    Haishan Wu
    Xiangyong Zeng
    World Journal of Surgical Oncology, 18
  • [4] Hsa_circ_0000231 knockdown inhibits the glycolysis and progression of colorectal cancer cells by regulating miR-502-5p/MYO6 axis
    Liu, Yanhe
    Li, Hui
    Ye, Xiaoyi
    Ji, Anlong
    Fu, Xiangwei
    Wu, Haishan
    Zeng, Xiangyong
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2020, 18 (01)
  • [5] Circular RNA Circ_0000119 promotes gastric cancer progression via circ_0000119/miR-502-5p/MTBP axis
    Xie, Mengyan
    Gu, Yunru
    Xu, Tingting
    Jing, Xinming
    Shu, Yongqian
    GENE, 2024, 908
  • [6] Hsa_circ_0008092 Contributes to Cell Proliferation and Metastasis in Hepatocellular Carcinoma via the miR-502-5p/CCND1 Axis
    Maimaiti, Yilihamu
    Kamali, Aihesan
    Yang, Peng
    Zhong, Kai
    Abuduhadeer, Xiaokaiti
    PROTEIN AND PEPTIDE LETTERS, 2022, 29 (07): : 595 - 604
  • [7] Knockdown of hsa_circ_0037658 inhibits the progression of osteoarthritis via inducing autophagy
    Cong Sui
    Debao Liu
    Yukang Que
    Shenglin Xu
    Yong Hu
    Human Cell, 2021, 34 : 76 - 85
  • [8] Knockdown of hsa_circ_0037658 inhibits the progression of osteoarthritis via inducing autophagy
    Sui, Cong
    Liu, Debao
    Que, Yukang
    Xu, Shenglin
    Hu, Yong
    HUMAN CELL, 2021, 34 (01) : 76 - 85
  • [9] Hsa_circ_0079557 Promotes the Proliferation of Colorectal Cancer Cells Through the hsa_circ_0079557/miR-502-5p/CCND1 Axis
    Yu, Chao
    Huang, Xue
    Huang, Renli
    Wang, Peiqi
    Cai, Zongda
    Guo, Zeyi
    Lan, Qingnan
    Cao, Haodi
    Yu, Jinlong
    CANCER GENOMICS & PROTEOMICS, 2023, 20 (06) : 567 - 581
  • [10] Depletion of hsa_circ_0000144 Suppresses Oxaliplatin Resistance of Gastric Cancer Cells by Regulating miR-502-5p/ADAM9 Axis
    Gao, Haifeng
    Xu, Jiajia
    Qiao, Fen
    Xue, Liangjun
    ONCOTARGETS AND THERAPY, 2021, 14 : 2773 - 2787